Home » Aethlon Medical Submits IDE to FDA for Hepatitis-C Study
Aethlon Medical Submits IDE to FDA for Hepatitis-C Study
Aethlon Medical submitted an investigational device exemption, or IDE, to the FDA requesting permission to initiate a clinical feasibility study of Hepatitis-C, or HCV, infected individuals enrolled to receive Hemopurifier therapy.
Equities
Equities
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May